Loading...
•
Dec 31, 2023
NeueHealth Q4 2023 Earnings Report
Reported strong full year results in Continuing Business and focused on serving all populations through differentiated, value-driven care model.
Key Takeaways
NeueHealth reported Q4 and full year 2023 results, highlighting a focus on care delivery and provider enablement after the sale of the California Medicare Advantage business. The NeueHealth business drove strong results in 2023, delivering $1.2 billion in revenue, up 55% year over year, and serving 461,000 consumers across the country.
Delivered strong full year 2023 results in Continuing Business
Focused on serving all populations through differentiated, value-driven care model
Served 461,000 consumers, an increase of 294% from prior year on a comparable basis
NeueCare and NeueSolutions segments well-positioned to drive strong performance in 2024
Forward Guidance
For full year 2024, NeueHealth is providing the following guidance and commentary:
Positive Outlook
- NeueHealth’s Enterprise Revenue is expected to be approximately $1 billion
- NeueCare Revenue is expected to be between $310 million and $320 million
- NeueSolutions Revenue is expected to be between $690 million and $700 million
- Enterprise Adjusted Operating Cost Ratio is expected to be between 15% and 16%
- Enterprise Adjusted EBITDA is expected to be between $15 million and $25 million in 2024
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...